ELABELA: A novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 7, 2014, Pages 620-622

  Xie, Feng ^a   Lv, Deguan ^a   Chen, Linxi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APLNR PROTEIN, HUMAN; ELA PEPTIDE, HUMAN; G PROTEIN COUPLED RECEPTOR; LIGAND; PEPTIDE HORMONE;

AMINO ACID SEQUENCE; CHEMISTRY; EMBRYOLOGY; HEART; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; HEART; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE HORMONES; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84903712144     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu032     Document Type: Article

References (36)

1. Chng SC, Ho L, Tian J and Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013, 27: 672-680.
2. Miura T, Luo Y, Khrebtukova I, Brandenberger R, Zhou D, Thies RS and Vasicek T, et al. Monitoring ea rly differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. Stem Cells Dev 2004, 13: 694-715.
3. Paluru P, Hudock KM, Cheng X, Mills JA, Ying L, Galvao AM and Lu L, et al. The negative impact ofWnt signaling on megakaryocyte and primitive erythroid progenitors derived from human embryonic stem cells. Stem Cell Res 2013, 12: 441-451.
4. Branford WW, Essner JJ and Yost HJ. Regulation of gut and heart left-right asymmetry by context-dependent interactions between xenopus lefty and BMP4 signaling. Dev Biol 2000, 223: 291-306.
5. Kuo TM, Taketani Y, Ayabe T, Tsutsumi O and Mizuno M. Stimulatory effect of epidermal growth factor on the development of mouse early embryos in vitro. Endocrinol Jpn 1991, 38: 485-490.
6. Zhang J, Yin JC and Wesley CS. From Drosophila development to adult: clues to Notch function in long-term memory. Front Cell Neurosci 2013, 7: 222.
7. Reeder AL, Zaremba KM, Liebl RM, Kowalkowski A and Nichol PF. Exogenous sonic hedgehog protein does not rescue cultured intestine from atresia formation. J Surg Res 2014, 187: 14-18.
8. Beyer TA, Weiss A, Khomc huk Y, Huang K, Ogunjimi AA, Varelas X and Wrana JL. Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 2013, 5: 1611-1624.
9. Ochi N, Takigawa N, Harada D, Yasugi M, Ichihara E, Hotta K and Tabata M, et al. Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer. Exp Cell Res 2014, 322: 168-177.
10. Lv D, Lu Q, Cao J and Chen L. Unanticipated role of apelin: regulation of miRNA generation. Acta Biochim Biophys Sin 2013, 45: 896-898.
11. Lv D, Li H and Che n L. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis. Acta Biochim Biophys Sin 2013, 45: 527-533.
12. Li LF, Pan WN, Chen F, Liao DF, Zhu BY and Chen LX. Effect of intravenous injection of apelin on the blood pressure, heart rate and baroreflex sensitivity. China J Mod Med 2007, 17: 1442-1445.
13. Scimia MC, Hurtado C, Ray S, Metzler S, Wei K, Wang J and Woods CE, et al. APJ acts as a dual receptor in cardiac hypertrophy. Nature 2012, 488: 394-398.
14. Inui M, Fukui A, Ito Y and Asashima M. Xapelin and Xmsr are re quired for cardiovascular development in Xenopus laevis. Dev Biol 2006, 298: 188-200.
15. Cox CM, D'Agostino SL, Miller MK, Heimark RL and Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006, 296: 177-189.
16. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY and Finsterbach TP, et al. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Cir Physiol 2009, 297: H1904-H1913.
17. Scott IC, Masri B, D'Amico LA, Jin SW, Jungblut B, Wehman AM and Baier H, et al. The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell 2007, 12: 403-413.
18. Pauli A,Norris ML,Valen E,Chew GL,Gagnon JA,Zimmerman S,Mitchell A,et al. Toddler: an embryonic signal that promotes cell movement via apelin receptors. Science 2014, 343: 1248636
19. Liu C, Su T, Li F, Li L, Qin X, PanWand Feng F, et al. PI3 K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell prolife ration induced by apelin-13. Acta Biochim Biophys Sin 2010, 42: 396-402.
20. Li F, Li L, Qin X, Pan W, Feng F, Chen F and Zhu B, et al. Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci 2008, 13: 3786-3792.
21. Li X, Zhang X, Li F, Chen L, Li L, Qin X and Gao J, et al. 14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells. Acta Biochim Biophys Sin 2010, 42: 403-409.
22. Maalouf RM, Eid AA, Gorin YC, Block K, Escobar GP, Bailey S and Abboud HE. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am J Physiol Cell Physiol 2012, 302: C597-C604.
23. Li L, Li L, Xie F, Zhang Z, Guo Y, Tang G and Lv D, et al. Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation. Acta Biochim B iophys Sin 2013, 45: 875-881.
24. Sorli SC, Le Gonidec S, Knibiehler B and Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007, 26: 7692-7699.
25. Kidoya H, Kunii N, Naito H, Muramatsu F, Okamoto Y, Nakayama T and Takakura N. The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy. Oncogene 2012, 31: 3254-3264.
26. Guo L, Li Q, Wang W, Yu P, Pan H, Li P and Sun Y, et al. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3- kinasephosphodiesterase 3B. Endocr Res 2009, 34: 142-154.
27. Galanth C, Hus-Citharel A, Li B and Llorens-Cortes C. Apelin in the control of body fluid homeostasis and cardiovascular functions. Curr Pharma Des 2012, 18: 789-798.
28. Knauf C, Drougard A, Fournel A, Duparc T and Valet P. Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders. Horm Metab Res 2013, 45: 928-934.
29. Xu H, Huang X, Arnlov J, Cederholm T, Stenvinkel P, Lindholm B and Riserus U, et al. Clinical correlates of insulin sensitivity and its associati on with mortality among men with CKD stages 3 and 4. Clin J Am Soc Nephrol 2014, .
30. Biondi B and Wartofsky L. Treatment with thyroid hormone. Endocr Rev 2014: er20131083.
31. Ellsworth A, Buck CL, Atkinson S and Hollmen T. Longitudinal monitoring of sex steroid hormones in excrement of spectacled eiders (Somateria fischeri). Gen Comp Endocrinol 2014, 198: 59-65.
32. Xu BH, Li MQ and Luo YJ. Treatment of premature ovarian failure patients by bushen tiaojing recipe combined hormone replacement therapy: a clinical observation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2013, 33: 1332-1335.
33. Agnarsson HR, Johannsson G and Ragnarsson O. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy. J Clin Endocrinol Met ab 2014: 99: 1479-1485
34. Li L, Zeng H and Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Cir Physiol 2012, 303: H605-H618.
35. Tempel D, de Boer M, van Deel ED , Haasdijk RA, Duncker DJ, Cheng C and Schulte-Merker S, et al. Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr? circulating cells. Cir Res 2012, 111: 585-598.
36. Lowenstein P, Yadav VN, Chockley P and Castro M. There must be a way out of here: identifying a safe and efficient combination of promoter, transgene, and vector backbone for gene therapy of neurological disease. Mol Ther 2014, 22: 246-247.